Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Subject Blinded, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail

NCT01080079 is registered in ClinicalTrials.gov with Nitric BioTherapeutics, Inc as lead sponsor.

NCT NCT01080079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01080079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Subject Blinded, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail
Lead sponsor
Nitric BioTherapeutics, Inc
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
June 30, 2012
Enrollment
168 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis